نتایج جستجو برای: sof

تعداد نتایج: 743  

2017
Zobair Younossi Maria Stepanova Masao Omata Masashi Mizokami Mercedes Walters Sharon Hunt

BACKGROUND Health utilities are preference-based measures for health states which are typically used in economic analyses to estimate quality-adjusted life years. Our aim is to report the standard SF-6D health utility scores in Japanese patients with hepatitis C virus (HCV) during treatment with different regimens. METHODS Japanese patients were enrolled in clinical trials of sofosbuvir (SOF)...

2015
David R Nelson James N Cooper Jacob P Lalezari Eric Lawitz Paul J Pockros Norman Gitlin Bradley F Freilich Ziad H Younes William Harlan Reem Ghalib Godson Oguchi Paul J Thuluvath Grisell Ortiz-Lasanta Mordechai Rabinovitz David Bernstein Michael Bennett Trevor Hawkins Natarajan Ravendhran Aasim M Sheikh Peter Varunok Kris V Kowdley Delphine Hennicken Fiona McPhee Khurram Rana Eric A Hughes

UNLABELLED Treatment options for patients with hepatitis C virus (HCV) genotype 3 infection are limited, with the currently approved all-oral regimens requiring 24-week treatment and the addition of ribavirin (RBV). This phase III study (ALLY-3; ClinicalTrials.gov: NCT02032901) evaluated the 12-week regimen of daclatasvir (DCV; pangenotypic nonstructural protein [NS]5A inhibitor) plus sofosbuvi...

2017
Masaaki Shimada Hiroaki Iwase Noboru Hirashima Nobumitsu Ryuge Noboru Urata

Background: In this retrospective study, we investigated nutritional status and liver steatosis after direct-acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection. Methods: One-hundred six patients with chronic HCV infection underwent HCV-RNA testing 12 weeks after the end of treatment (EOT) with DAAs from September 2014 to August 2016. HCV genotype 1 patients received ...

2016
Christoph R Werner Julia M Schwarz Daniel P Egetemeyr Robert Beck Nisar P Malek Ulrich M Lauer Christoph P Berg

AIM To gather data on the antiviral efficacy and safety of second generation direct acting antiviral (DAA) treatment with respect to sustained virological response (SVR) 12 wk after conclusion of treatment, and to determine predictors of SVR12 in this setting. METHODS Two hundred and sixty patients treated with SOF combination partners PR (n = 51), R (n = 10), SMV (n = 30), DCV (n = 81), LDV ...

2011
Mahdi Hajian Seyed Morteza Hosseini Vajiheh Asgari Somayyeh Ostadhoosseini Mohsen Forouzanfar Mohammad Hossein Nasr Esfahani

BACKGROUND This study investigated the effect of two in vitro embryo culture systems (co-culture system versus cell-free sequential-media) on developmental competence, cryosurvival and DNA- fragmentation of in vitro developed bovine blastocysts. MATERIALS AND METHODS Bovine presumptive zygotes were cultured in Ménézo's B2 (B2) plus vero-cells or sequential synthetic oviductal fluid (SOF) for ...

2017
Avin Aggarwal Eric R. Yoo Ryan B. Perumpail George Cholankeril Radhika Kumari Tami J. Daugherty Alex S. Lapasaran Aijaz Ahmed

Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation. Methods: We performed a retrospective analysis of 14 patients with CHC and ESRD on dialysis who received 15 courses of SOF-base...

Journal: :Journal of lipid research 1995
H Campos D M Dreon R M Krauss

To test whether lipoprotein lipase or hepatic lipase activities are associated with lipoprotein subclasses, and to assess the effects of dietary manipulations on these associations, enzyme activities were measured in postheparin plasma (75 U heparin/kg) from 43 healthy men who were randomly allocated to a low-fat (24% fat, 60% carbohydrate) and a high-fat (46% fat, 38% carbohydrate) diet for 6 ...

2017
Amy Puenpatom Michael Hull Jeffrey McPheeters Kay Schwebke

INTRODUCTION Ledipasvir/sofosbuvir (LDV/SOF) for hepatitis C virus (HCV) treatment provides an oral interferon-free treatment regimen with high rates of sustained virologic response (SVR). This study assessed treatment discontinuation, factors associated with treatment completion, and real-world effectiveness. METHODS Patients with HCV treated with LDV/SOF between October 2014 and June 2015 a...

2018
Masayoshi Yada Masayuki Miyazaki Kosuke Tanaka Akihide Masumoto Kenta Motomura

AIM To investigate the real-world efficacy and safety of sofosbuvir/ribavirin (SOF/RBV) therapy for Japanese patients with genotype 2 hepatitis C virus (GT2-HCV). METHODS A total of 182 patients with GT2-HCV infection who received SOF/RBV therapy for 12 wk at our hospital were enrolled. The patients comprised 122 men and 60 women (age range: 17-84 years; mean age ± SD: 60.1 ± 12.1 years). Relat...

2014
Keisuke Yoshino Koji Nakamura Arisa Yamashita Yoshihiko Abe Kazuhiro Iwasaki Yukie Kanazawa Kaori Funatsu Tsuyoshi Yoshimoto Shigeru Suzuki

The functionality of a newly developed silicone oil-free (SOF) syringe system, of which the plunger stopper is coated by a novel coating technology (i-coating™), was assessed. By scanning electron microscopy observations and other analysis, it was confirmed that the plunger stopper surface was uniformly covered with the designed chemical composition. A microflow imaging analysis showed that the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید